Effects of metrifonate, a long-acting cholinesterease inhibitor, in alzheimer disease: Report of an open trial
- 1 January 1990
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 19 (4) , 425-434
- https://doi.org/10.1002/ddr.430190407
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Physostigmine, tacrine and metrifonate: The effect of multiple doses on acetylcholine metabolism in rat brainNeuropharmacology, 1989
- Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspectsDrug Development Research, 1988
- A comparison of the effects of two inhibitors on brain cholinesteraseNeuropharmacology, 1987
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Levels of Metrifonate and Dichlorvos in Plasma and Erythrocytes during Treatment of Schistosomiasis with Bilarcil®Acta Pharmacologica et Toxicologica, 1981
- Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.BMJ, 1978
- NEOCORTICAL CHOLINERGIC NEURONS IN ELDERLY PEOPLEThe Lancet, 1977
- “Mini-mental state”Journal of Psychiatric Research, 1975
- MULTI-INFARCT DEMENTIA A CAUSE OF MENTAL DETERIORATION IN THE ELDERLYThe Lancet, 1974